The mode of action of migraine triggers: A hypothesis

Headache

Volumn 49, Issue 2, 2009, Pages 253-275

  Lambert, Geoffrey A ^a,b   Zagami, Alessandro S ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Brainstem; Cerebral cortex; Migraine; Migraine trigger; Trigeminovascular sensory system

Indexed keywords

5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN GENE RELATED PEPTIDE; CYPROHEPTADINE; DIHYDROERGOTAMINE; DRINKING WATER; ELETRIPTAN; ERGOT ALKALOID; EXCITATORY AMINO ACID; IPSAPIRONE; MAGNESIUM; METHYSERGIDE; METITEPINE; MONOAMINE OXIDASE INHIBITOR; NARATRIPTAN; PROPRANOLOL; SEROTONIN; SUBSTANCE P; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID;

ALLODYNIA; BLOOD VESSEL; BLOOD VESSEL REACTIVITY; BRAIN CELL; BRAIN CORTEX; BRAIN STEM; DIRECT CURRENT; DURA MATER; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION; ENVIRONMENTAL CHANGE; EPILEPSY; FLUSHING; FOOD; HEADACHE; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIGHT; LOCUS CERULEUS; MAGNESIUM DEFICIENCY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; NERVE CELL MEMBRANE POTENTIAL; NOISE; NONHUMAN; ODOR; PAIN; PARESTHESIA; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAPHE MAGNUS NUCLEUS; REVIEW; SENSATION; SENSORY DYSFUNCTION; SENSORY NERVE; SENSORY SYSTEM; SIDE EFFECT; SKIN TINGLING; SPREADING CORTICAL DEPRESSION; STRESS; TEMPERATURE; TRANSCRANIAL MAGNETIC STIMULATION; WARM SENSATION;

HUMANS; MIGRAINE DISORDERS; PERIAQUEDUCTAL GRAY; RAPHE NUCLEI;

EID: 59449100080     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01230.x     Document Type: Review

References (243)

1. Critchley M. Migraine from cappadocia to queens square. In : Smith R, ed. Background to Migraine. London : Heinemann 1967 : 28.
2. Humphrey PP, Goadsby PJ. The mode of action of sumatriptan is vascular? A debate. Cephalalgia. 1994 14 : 401 410.
3. Loder E, Harrington MG, Cutrer M, Sandor P, De Vries B. Selected confirmed, probable, and exploratory migraine biomarkers. Headache. 2006 46 : 1108 1127.
4. Loder E, Rizzoli P. Biomarkers in migraine: Their promise, problems, and practical applications. Headache. 2006 46 : 1046 1058.
5. De Vries B, Haan J, Frants RR, Van den Maagdenberg AMJM, Ferrari MD. Genetic biomarkers for migraine. Headache. 2006 46 : 1059 1068.
6. Gantenbein AR, Sandor PS. Physiological parameters as biomarkers of migraine. Headache. 2006 46 : 1069 1074.
7. Harrington MG. Cerebrospinal fluid biomarkers in primary headache disorders. Headache. 2006 46 : 1075 1087.
8. Edvinsson L. Neuronal signal substances as biomarkers of migraine. Headache. 2006 46 : 1088 1094.
9. Cutrer FM, Black DF. Imaging findings of migraine. Headache. 2006 46 : 1095 1107.
10. Sanchez-del-Rio M, Reuter U, Moskowitz MA. New insights into migraine pathophysiology. Curr Opin Neurol. 2006 19 : 294 298.
11. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007 13 : 39 44.
12. Ray BS, Wolff HG. Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg. 1940 41 : 813 856.
13. Schiller F. The migraine tradition. Bull Hist Med. 1975 49 : 1 19.
14. Ekbom K, Kudrow L. Facial flush in cluster. Headache. 1979 19 : 47.
15. Humphrey PPA. 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol. 1991 238 : S38 44.
16. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. In: Proceedings of the Association into Nervous and Mental Disease. 1937 : 638 669.
17. Sakai F, Meyer JS. Regional cerebral hemodynamics during migraine and cluster headaches measured by the 133-Xe inhalation method. Headache. 1978 18 : 122 132.
18. Saxena PR. Arteriovenous shunting and migraine. Res Clin Stud Headache. 1978 6 : 89 102.
19. D'Andrea G, Cananzi AR, Perini F, Hasselmark L. Platelet models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia. 1995 15 : 265 271.
20. Theoharides TC, Spanos C, Pang XZ, et al. Stress-induced intracranial mast cell degranulation - A corticotropin-releasing hormone-mediated effect. Endocrinol. 1995 136 : 5745 5750.
21. Liveing E. On Megrim, Sick-Headache and Some Allied Disorders. London : Churchill 1873.
22. Zanchin G. Sources. J Headache Pain. 2004 5 : 261 264.
23. Hardebo JE. Migraine - Why and how a cortical excitatory wave may initiate the aura and headache. Headache. 1991 31 : 213 221.
24. Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache. 2001 41 : 629 637.
25. MacKenzie ET, Edvinsson L, Scatton B. Functional bases for a central serotonergic involvement in classic migraine: A speculative view. Cephalalgia. 1985 5 : 69 78.
26. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW. Brainstem influences on the cephalic circulation: Experimental data from cat and monkey of relevance to the mechanism of migraine. Headache. 1983 23 : 258 265.
27. 1-receptor agonist naratriptan in rat. Pain. 2001 90 : 227 231.
28. Goadsby PJ, Lambert GA, Lance JW. Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation. Brain Res. 1982 249 : 247 254.
29. Montagna P. Hypothalamus, sleep and headaches. Neurol Sci. 2006 27 : s138 s143.
30. Overeem S, van Vliet JA, Lammers GJ, Zitman FG, Swaab DF, Ferrari MD. The hypothalamus in episodic brain disorders. Lancet Neurol. 2002 1 : 437 444.
31. Peres MFP, del Rio MS, Seabra MLV, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001 71 : 747 751.
32. Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol. 2005 493 : 9 14.
33. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: A role in migraine? Brain. 2005 128 : 86 97.
34. Edvinsson L, Ekman R, Jansen I, Ottosson A, Uddman R. Peptide-containing nerve fibers in human cerebral arteries: Immunocytochemistry, radioimmunoassay, and in vitro pharmacology. Ann Neurol. 1987 21 : 431 437.
35. Edvinsson L, Jansen I, Cunha ESM, Gulbenkian S. Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries. Cephalalgia. 1994 14 : 88 96.
36. Moskowitz MA. The anatomy and neurochemistry of trigeminovascular neurons. In : Owman C, Hardebo JE, eds. Neural Regulation of Brain Circulation. Amsterdam : Elsevier 1986 : 393 405.
37. Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994 15 : 149 153.
38. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol. 2000 47 : 614 624.
39. Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: A role in migraine? Neuroscience. 2001 106 : 793 800.
40. Basbaum AI, Fields HL. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984 7 : 309 338.
41. Lambert GA, Hoskin KL, Zagami AS. Cortico-NRM influences on trigeminovascular sensation. Cephalalgia. 2008 28 : 640 652.
42. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007 27 : 394 402.
43. Lance JW, Goadsby PJ. Mechanism and Management of Headache, 6th edn. London : Butterworth Scientific 1999.
44. Welch KMA, D'Andrea G, Tepley N, Barkeley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Headache. 1990 8 : 817 828.
45. Schoenen J. The cerebral cortex in migraine pathogenesis: Culprit or bystander? A neurophysiological approach. In: Proceedings of the 16th Migraine Trust International Symposium. 2006 : 10.
46. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia. 2007 27 : 1427 1439.
47. Palmer JE, Chronicle EP, Rolan P, Mulleners WM. Cortical hyperexcitability is cortical under-inhibition: Evidence from a novel functional test of migraine patients. Cephalalgia. 2000 20 : 525 532.
48. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld J-W. Visual cortex excitability in migraine with and without aura. Headache. 2001 41 : 565 572.
49. Mulleners WM, Chronicle EP, Vredeveld JW, Koehler PJ. Cortical excitability in migraine. Ann Neurol. 1999 45 : 415 416.
50. Welch KM. Brain hyperexcitability: The basis for antiepileptic drugs in migraine prevention. Headache. 2005 45 : S25 S32.
51. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003 4 : 386 398.
52. Custers A, Mulleners WM, Chronicle EP. Assessing cortical excitability in migraine: Reliability of magnetic suppression of perceptual accuracy technique over time. Headache. 2005 45 : 1202 1207.
53. Pietrobon D. Migraine: New molecular mechanisms. Neuroscientist. 2005 11 : 373 386.
54. van den Maagdenberg AMJM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004 41 : 701 710.
55. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev. 2001 81 : 1065 1096.
56. Kager H, Wadman WJ, Somjen GG. Simulated seizures and spreading depression in a neuron model incorporating interstitial space and ion concentrations. J Neurophysiol. 2000 84 : 495 512.
57. Liebetanz D, Fregni F, Monte-Silva KK, et al. After-effects of transcranial direct current stimulation (tDCS) on cortical spreading depression. Neurosci Lett. 2006 398 : 85 90.
58. Brennan K, Romero RM, López Valdés H, Arnold A, Charles A. Reduced threshold for cortical spreading depression in female mice. Ann Neurol. 2007 61 : 603 606.
59. Gupta S, Mehrotra S, Villalon CM, et al. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Therapeut. 2007 113 : 321 340.
60. Nedeltchev K, Arnold M, Schwerzmann M, et al. Cerebrovascular response to repetitive visual stimulation in interictal migraine with aura. Cephalalgia. 2004 24 : 700 706.
61. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol. 2004 55 : 276 280.
62. 2+ channel gene CACNL1A4. Cell. 1996 87 : 543 552.
63. Fusco MD, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump [alpha]2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003 33 : 192 196.
64. Forderreuther S, Henkel A, Noachtar S, Straube A. Headache associated with epileptic seizures: Epidemiology and clinical characteristics. Headache. 2002 42 : 649 655.
65. De Simone R, Ranieri A, Marano E, et al. Migraine and epilepsy: Clinical and pathophysiological relations. Neurol Sci. 2007 28 : S150 155.
66. Lance JW, Adams RW, Lambert GA. Bulbocortical pathways and their possible relevance to migraine and epilepsy. Funct Neurol. 1987 1 : 357 361.
67. Welch KMA, Lewis D. Migraine and epilepsy. Neurol Clin. 1997 15 : 107 114.
68. Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants RR, Ferrari MD. Migraine, ataxia and epilepsy: A challenging spectrum of genetically determined calcium channelopathies. Eur J Hum Genet. 1998 6 : 297 307.
69. Panayiotopoulos CP. Visual phenomena and headache in occipital epilepsy: A review, a systematic study and differentiation from migraine. Epileptic Disord. 1999 1 : 205 216.
70. Reis J, Tergau F, Hamer HM, et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia. 2002 43 : 1149 1156.
71. Reutens DC, Berkovic SF, Macdonell RAL, Bladin PF. Magnetic stimulation of the brain in generalized epilepsy: Reversal of cortical hyperexcitability by anticonvulsants. Ann Neurol. 1993 34 : 351 355.
72. Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: A Cochrane review. Cephalalgia. 2008 28 : 585 597.
73. Datto C, Kastenberg J, Miller D, Knight D. Prophylactic measures for ECT-induced migraine headaches. J ECT. 1998 14 : 135.
74. Weiner SJ, Ward TN, Ravaris CL. Headache and electroconvulsive therapy. Headache. 1994 34 : 155 159.
75. DeBattista C, Mueller K. Sumatriptan prophylaxis for postelectroconvulsive therapy headaches. Headache. 1995 35 : 502 503.
76. Hawken ER, Delva NJ, Lawson JS. Successful use of propranolol in migraine associated with electroconvulsive therapy. Headache. 2001 41 : 92 96.
77. Bindman LJ, Lippold OCJ, Redfearn JWT. The action of brief polarizing currents on the cerebral cortex of the rat (1) during current flow and (2) in the production of long-lasting after-effects. J Physiol. 1964 173 : 369 382.
78. Antal A, Kincses TZ, Nitsche MA, Bartfai O, Paulus W. Excitability changes induced in the human primary visual cortex by transcranial direct current stimulation: Direct electrophysiological evidence. Invest Ophthalmol Vis Sci. 2004 45 : 702 707.
79. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 527 : 633 639.
80. Aurora SK, Ahmad BK, Welch KM, Bhardhwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology. 1998 50 : 1111 1114.
81. Clarke B, Upton A, Kamath M, Al-Harbi T, Castellanos C. Transcranial magnetic stimulation for migraine: Clinical effects. Headache. 2006 7 : 341 346.
82. Piper R. Effects of spreading depression on physiological activation of the cerebral cortex in the cat. In : Olesen J, ed. Migraine and Other Headaches: The Vascular Symptoms. New York : Raven Press 1991 : 177 180.
83. Sobel N, Prabhakaran V, Zhao Z, et al. Time course of odorant-induced activation in the human primary olfactory cortex. J Neurophysiol. 2000 83 : 537 551.
84. Binder JR, Frost JA, Hammeke TA, et al. Human temporal lobe activation by speech and nonspeech sounds. Cereb Cortex. 2000 10 : 512 528.
85. Dietrich T, Krings T, Neulen J, et al. Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. NeuroImage. 2001 13 : 425 432.
86. Welch KM. Contemporary concepts of migraine pathogenesis. Neurology. 2003 61 : S2 S8.
87. Welch M. The occipital cortex as a generator of migraine aura. Cephalalgia. 1998 18 : 15 18.
88. Russell MB, Rasmussen BK, Thorvaldsen PER, Olesen JES. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995 24 : 612 618.
89. Dennis M, Warlow C. Migraine aura without headache: Transient ischaemic attack or not? J Neurol Neurosurg Psychiatry. 1992 55 : 437 440.
90. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002 8 : 136 142.
91. Lambert GA, Michalicek J. Cortical spreading depression reduces dural blood flow - A possible mechanism for migraine pain? Cephalalgia. 1994 14 : 430 436.
92. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993 13 : 1167 1177.
93. Ingvardsen BK, Laursen H, Olsen UB, Hansen AJ. Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression. Pain. 1997 72 : 407 415.
94. Takano T, Tian G-F, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007 10 : 754 762.
95. Kunkler PE, Kraig RP. Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus. 2003 13 : 835 844.
96. Moskowitz MA. The emerging importance of cortical spreading depression in migraine headache. Rev Neurol. 2005 161 : 655 657.
97. Dalkara T, Zervas N, Moskowitz M. From spreading depression to the trigeminovascular system. Neurol Sci. 2006 27 : s86 s90.
98. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004 113 : 1447 1455.
99. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006 59 : 652 661.
100. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache. 1987 27 : 416 420.
101. Basbaum AI. The neurobiology of pain: Molecules and mechanisms. Cephalalgia. 2006 26 : 1352.
102. Basbaum AI, Fields HL. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984 7 : 309 338.
103. Dostrovsky JO, Shah Y, Gray BG. Descending inhibitory influences from periaqueductal gray, nucleus raphe magnus, and adjacent reticular formation. II. Effects on medullary dorsal horn nociceptive and non-nociceptive neurons. J Neurophysiol. 1983 49 : 948 960.
104. Mokha SS, McMillan JA, Iggo A. Pathways mediating descending control of spinal nociceptive transmission from the nuclei locus coeruleus (LC) and raphe magnus (NRM) in the cat. Exp Brain Res. 1986 61 : 597 606.
105. Pinardi G, Sierralta F, Miranda HF. Adrenergic mechanisms in antinociceptive effects of non steroidal anti-inflammatory drugs in acute thermal nociception in mice. Inflamm Res. 2002 51 : 219 222.
106. Matharu MS. The hypothalamus, pain, and primary headaches. Headache. 2007 47 : 963 968.
107. Lambert GA, Lowy AJ, Boers PM, Angus-Leppan H, Zagami AS. The spinal cord processing of input from the superior sagittal sinus: Pathway and modulation by ergot alkaloids. Brain Res. 1992 597 : 321 330.
108. Patrick WM. Forebrain projections to the periaqueductral gray in the monkey, with observations in the cat and rat. J Comp Neurol. 1982 206 : 146 158.
109. Arbab MA, Delgado Zygmunt TJ, Shiokawa Y, Svendgaard NA. Central projections of the sensory innervation to the middle cerebral artery in the squirrel monkey. Acta Neurochir Wien. 1992 119 : 104 110.
110. Keay KA, Bandler R. Vascular head pain selectively activates ventrolateral periaqueductal gray in the cat. Neurosci Lett. 1998 245 : 58 60.
111. Bandler R, Keay KA. Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression. Prog Brain Res. 1996 107 : 285 300.
112. Bandler R, Shipley MT. Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression? Trends Neurosci. 1994 17 : 379 389.
113. Mason P. Deconstructing endogenous pain control modulations. J Neurophysiol. 2005 94 : 1659 1663.
114. Cui M, Feng Y, McAdoo DJ, Willis WD. Periaqueductal gray stimulation-induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J Pharmacol Exp Ther. 1999 289 : 868 876.
115. Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol. 1997 14 : 2 31.
116. Behbehani MM. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol. 1995 46 : 575 605.
117. Gebhart GF, Sandkuhler J, Thalhammer JG, Zimmermann M. Inhibition in spinal cord of nociceptive information by electrical stimulation and morphine microinjection at identical sites in midbrain of the cat. J Neurophysiol. 1984 51 : 75 89.
118. Tracey I, Ploghaus A, Gati JS, et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci. 2002 22 : 2748 2752.
119. Hoskin KL, Bulmer DC, Lasalandra M, Jonkman A, Goadsby PJ. Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat. 2001 198 : 29 35.
120. Nichols DS, Thorn BE, Berntson GG. Opiate and serotonergic mechanisms of stimulation-produced analgesia within the periaqueductal gray. Brain Res Bull. 1989 22 : 717 724.
121. Cameron AA, Khan IA, Westlund KN, Cliffer KD, Willis WD. The efferent projections of the periaqueductal gray in the rat: A Phaseolus vulgaris-leucoagglutin study. II descending projections. J Comp Neurol. 1995 351 : 585 601.
122. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 1 : 658 660.
123. Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol. 2005 62 : 1270 1275.
124. Veloso F, Kumar K, Toth C. Headache secondary to deep brain implantation. Headache. 1998 38 : 507 515.
125. Haas DC, Kent PF, Friedman DI. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache. 1993 33 : 452 455.
126. Goadsby PJ. Neurovascular headache and a midbrain vascular malformation: Evidence for a role of the brainstem in chronic migraine. Cephalalgia. 2002 22 : 107 111.
127. Welch KM. Concepts of migraine headache pathogenesis: Insights into mechanisms of chronicity and new drug targets. Neurol Sci. 2003 24 (Suppl. 2 S149 S153.
128. 3H-dihydroergotamine- binding sites in the cat central nervous system: Relevance to migraine. Ann Neurol. 1991 29 : 91 94.
129. Bartsch T, Knight YE, Goadsby PJ. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol. 2004 56 : 371 381.
130. Carlton SM, Leichnetz GR, Young EG, Mayer DJ. Supramedullary afferents of the nucleus raphe magnus in the rat: A study using the transcannula HRP gel and autoradiographic techniques. J Comp Neurol. 1983 214 : 43 58.
131. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci. 2006 101 : 107 117.
132. Travagli RA, Williams JT. Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea-pig. J Physiol. 1996 491 : 177 185.
133. 1D receptors sited on different neurons and involved in different functions. Br J Pharmacol. 1999 126 : 607 612.
134. Fields HL, Bry J, Hentall I, Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci. 1983 3 : 2545 2552.
135. Gao KM, Chen DO, Genzen JR, Mason P. Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia. J Neurosci. 1998 18 : 1860 1868.
136. Schnell C, Ulucan C, Ellrich J. Atypical on-, off- and neutral cells in the rostral ventromedial medulla oblongata in rat. Exp Brain Res. 2002 145 : 64 75.
137. Anthony M, Hinterberger H, Lance JW. Plasma serotonin in migraine and stress. Arch Neurol. 1967 16 : 544 552.
138. 1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. Neuroreport. 1998 9 : 2605 2608.
139. Hamel E. The biology of serotonin receptors: Focus on migraine pathophysiology and treatment. Can J Neurol Sci. 1999 26 : S2 S6.
140. Hargreaves RJ, Shepheard SL. Pathophysiology of migraine - New insights. Can J Neurol Sci. 1999 26 : S12 S19.
141. Dahlstrom A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand. 1964 232 (Suppl 1 55.
142. Dahlstrom A, Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. II Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems. Acta Physiol Scand. 1965 247 (Suppl 1 36.
143. Fog-Moller F, Genefke IK, Bryndum B. Changes in concentration of catecholamines in blood during spontaneous migraine attacks and reserpine-induced attacks. In : Greene R, ed. Current Concepts in Migraine. New York : Raven Press 1978 : 115 119.
144. Genefke IK, Dalsgaard Nielsen T, Bryndum B, Fog Moller F, Jensen JA. Concentration of serotonin in blood platelets: Effect of reserpine in migraineurs. Headache. 1975 15 : 136 138.
145. Joseph R, Welch KM, D'Andrea G. Serotonergic hypofunction in migraine: A synthesis of evidence based on platelet dense body dysfunction. Cephalalgia. 1989 9 : 293 299.
146. Couture R, Cuello AC. Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat. J Physiol. 1984 346 : 273 285.
147. Fornal CA, Litto WJ, Metzler CW, Marrosu F, Tada K, Jacobs BL. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. J Pharmacol Exp Ther. 1994 270 : 1345 1358.
148. Sprouse J, Aghajanian G. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neurons. Neuropharmacol. 1988 27 : 707 715.
149. Fornal C, Auerbach S, Jacobs BL. Activity of serotonin-containing neurons in nucleus raphe magnus in freely moving cats. Exp Neurol. 1985 88 : 590 608.
150. Lapierre YD, Silverstone P, Reesal RT, et al. A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression. J Clin Psychopharmacol. 1998 18 : 268 273.
151. Yu X-M, Hua M, Mense S. The effects of intracerebroventricular injection of naloxone, phentolamine and methysergide on the transmission of nociceptive signals in rat dorsal horn neurons with convergent cutaneous-deep input. Neurosci. 1991 44 : 715 723.
152. Fozard JR, Gray JA. 5-HT1C receptor activation: A key step in the initiation of migraine? Trends Pharmacol Sci. 1989 10 : 307 309.
153. 1A receptors in the dorsal raphe and hippocampus : I. Effect of spiperone. J Pharmacol Exp Ther. 1993 265 : 7 15.
154. De Vries P, Villalon CM, Saxena PR. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur J Pharmacol. 1999 375 : 61 74.
155. Schoenen J. Acute migraine therapy: The newer drugs. Curr Opin Neurol. 1997 10 : 237 243.
156. 1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons. Neuropharmacology. 2002 42 : 374 385.
157. Tashiro T, Ruda MA, Satoda T, Matsushima R, Mizuno N. Convergence of serotonin-, enkephalin-, and substance P-like immunoreactive afferent fibers onto cat medullary dorsal horn projection neurons: A triple immunocytochemical staining technique combined with the retrograde HRP-tracing method. Brain Res. 1989 491 : 360 365.
158. May A, Gamulescu MA, Bogdahn U, Lohmann CP. Intractable eye pain: Indication for triptans. Cephalalgia. 2002 22 : 195 196.
159. Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: Implications for the selective antimigraine action of triptans. J Neurosci. 2003 23 : 10988 10997.
160. 1B/1D) receptor - A central action in migraine. Ann Neurol. 1998 43 : 711 718.
161. Lambert GA, Shimomura T, Boers P, Gordon V, Donaldson C, Zagami AS. Serotonin infusions inhibit sensory input from the dural vasculature. Cephalalgia. 1999 19 : 639 650.
162. Sessle BJ, Hu JW, Dubner R, Lucier GE. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effect of naloxone. J Neurophysiol. 1981 45 : 193 207.
163. 1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalalgia. 1997 17 : 833 842.
164. Potrebic S, Raskin NH. New abortive agents for the treatment of migraine. Adv Intern Med. 2001 46 : 1 29.
165. Goldstein DJ, Roon KI, Offen WW, et al. Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: A randomised controlled trial. Lancet. 2001 358 : 1230 1234.
166. Burstein R, Jakubowski M, Levy D. Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociception. Pain. 2005 115 : 21 28.
167. 1B/1D receptors in the cat: Implications for migraine therapy. Cephalalgia. 2004 24 : 99 109.
168. Linde M, Elam M, Lundblad L, Olausson H, Dahlof C. Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia. Cephalalgia. 2004 24 : 1057 1066.
169. Dodick D, Martin V. Triptans and CNS side-effects: Pharmacokinetic and metabolic mechanisms. Cephalalgia. 2004 24 : 417 424.
170. Gallagher RM, Dennish G, Spierings ELH, Chitra R. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache. 2000 40 : 119 128.
171. Barger G. Ergot and Ergotism. A Monograph. London : Gurney and Jackson 1931.
172. Wellcome HS. From Ergot to "Ernutin" - An Historical Sketch. Melbourne : Burroughs Wellcome and Co 1908.
173. 1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002 22 : 633 658.
174. 1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Res. 2004 998 : 91 99.
175. Stamford JA. Descending control of pain. Br J Anaesth. 1995 75 : 217 227.
176. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev. 2003 42 : 33 84.
177. Jodoj E, Chiang C, Aston-Jones G. Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neurosci. 1998 83 : 63 79.
178. Luppi PH, Aston-Jones G, Akaoka H, Chouvet G, Jouvet M. Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neurosci. 1995 65 : 119 160.
179. Aston Jones G, Shipley MT, Chouvet G, et al. Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. Prog Brain Res. 1991 88 : 47 75.
180. Bajic D, Proudfit HK, Bockstaele EJV. Periaqueductal gray neurons monosynaptically innervate extranuclear noradrenergic dendrites in the rat pericoerulear region. J Comp Neurol. 2000 427 : 649 662.
181. Mokha SS, McMillan JA, Iggo A. Descending control of spinal nociceptive transmission. Actions produced on spinal multireceptive neurones from the nuclei locus coeruleus (LC) and raphe magnus (NRM). Exp Brain Res. 1985 58 : 213 226.
182. Basbaum AI, Fields HL. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984 7 : 309 338.
183. Simpson KL, Altman DW, Wang L, Kirifides ML, Lin RCS, Waterhouse BD. Lateralization and functional organization of the locus coeruleus projection to the trigeminal somatosensory pathway in rat. J Comp Neurol. 1997 385 : 135 147.
184. Igarashi S, Sasa M, Takaori S. Feedback loop between locus coeruleus and spinal trigeminal nucleus neurons responding to tooth pulp stimulation in the rat. Brain Res Bull. 1979 4 : 75 83.
185. Craig AD. Spinal and trigeminal lamina I input to the locus coeruleus anterogradely labeled with Phaseolus vulgaris leucoagglutinin (PHA-L) in the cat and the monkey. Brain Res. 1992 584 : 325 328.
186. Sasa M, Takaori S. Influence of the locus coeruleus on transmission in the spinal trigeminal nucleus neurons. Brain Res. 1973 55 : 203 208.
187. Sasa M, Munekiyo K, Ikeda H, Takaori S. Noradrenaline mediated inhibition by locus coeruleus of spinal trigeminal neurons. Brain Res. 1974 80 : 443 460.
188. Tsuruoka M, Arai Y-CP, Nomura H, Matsutani K, Willis WD. Unilateral hindpaw inflammation induces bilateral activation of the locus coeruleus and the nucleus subcoeruleus in the rat. Brain Res Bull. 2003 61 : 117 123.
189. Margalit D, Segal M. A pharmacologic study of analgesia produced by stimulation of the nucleus locus coeruleus. Psychopharmacol. 1979 62 : 169 173.
190. Morrison JH, Foote SL, Molliver ME, Bloom FE, Lidov HG. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: An immunohistochemical study. Proc Natl Acad Sci U S A. 1982 79 : 2401 2405.
191. Adams RW, Lambert GA, Lance JW. Stimulation of brainstem nuclei in the cat: Effect on neuronal activity in the primary visual cortex of relevance to cerebral blood flow and migraine. Cephalalgia. 1989 9 : 107 118.
192. Raichle ME, Hartman BK, Eichling JO, Sharpe LG. Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci U S A. 1975 72 : 3726 3730.
193. Goadsby PJ, Lambert GA, Lance JW. Dilatation in the carotid vascular territory of the cat in response to activation of cell bodies in the locus coeruleus. Clin Exp Neurol. 1984 20 : 63 72.
194. Goadsby PJ, Lambert GA, Lance JW. The mechanism of cerebrovascular vasoconstriction in response to locus coeruleus stimulation. Brain Res. 1985 326
195. Aghajanian GK, Cederbaum JM, Wang RY. Evidence for norepinephrine- mediated collateral inhibition of the locus coeruleus neurons. Brain Res. 1977 136 : 570 577.
196. Cederbaum JM, Aghajanian GK. Noradrenergic neurons of the locus coeruleus inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Res. 1976 112 : 413 449.
197. Cederbaum JM, Aghajanian GK. Catecholamine receptors on locus coeruleus neurons-pharmacological characterization. Eur J Pharmacol. 1977 44 : 375 385.
198. Guyenet PG, Aghajanian GK. Excitation of neurons in the locus coeruleus by substance P and related peptides. Brain Res. 1977 136 : 178 184.
199. Korf J, Bunney BS, Aghajanian GK. Noradrenergic neurons: Morphine inhibition of spontaneous activity. Eur J Pharmacol. 1974 25 : 165 169.
200. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KMA. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology. 2002 59 : 72 78.
201. Kelman L. The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs. Headache. 2004 44 : 865 872.
202. Lance JW, Goadsby PJ. Mechanism and Management of Headache, 7th edn. London : Butterworth Scientific 2005.
203. Dodick DW, Eross EJ, Parish JM. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache. 2003 43 : 282 292.
204. Solomon GD. Circadian rhythms and migraine. Cleve Clin J Med. 1992 59 : 326 329.
205. Drummond PD, Lance JW. Neurovascular disturbances in headache patients. Clin Exp Neurol. 1984 20 : 93 99.
206. Myers JMG. Editorial focus on the review series on metabolic sensing and regulation by the hypothalamus. Am J Physiol Endocrinol Metab. 2008 (in press).
207. Yu Y-H, Blessing WW. Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits. Auton Neurosci. 2001 87 : 236 242.
208. Hsieh J-C, Ståhle-Bäckdahl M, Hägermark Ö, Stone-Elander S, Rosenquist G, Ingvar M. Traumatic nociceptive pain activates the hypothalamus and the periaqueductal gray: A positron emission tomography study. Pain. 1996 64 : 303 314.
209. Benjamin L, Levy MJ, Lasalandra MP, et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: A Fos study. Neurobiol Dis. 2004 16 : 500 505.
210. 3 receptors in the rat spinal cord dorsal horn. Neurosci. 2005 135 : 1255 1268.
211. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007 47 : 1418 1426.
212. May A, Bahra A, Buchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998 352 : 275 278.
213. Dodick D, Rozen T, Goadsby P, Silberstein S. Cluster headache. Cephalalgia. 2000 20 : 787 803.
214. Holland P, Goadsby PJ. The hypothalamic orexinergic system: Pain and primary headaches. Headache. 2007 47 : 951 962.
215. Cohen A, Goadsby P. Functional neuroimaging of primary headache disorders. Curr Pain Headache Rep. 2005 9 : 141 146.
216. Goadsby PJ, May A. PET demonstration of hypothalamic activation in cluster headache. Neurology. 1999 52 : 1522.
217. Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle TR. SUNCT: Bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain. 2005 113 : 422 426.
218. Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RS, Goadsby PJ. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache. 2004 44 : 747 761.
219. Franzini A, Ferroli P, Leone M, Broggi G. Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: First reported series. Neurosurg online. 2003 52 : 1095 1101.
220. Rasche D, Foethke D, Gliemroth J, Tronnier V. Tiefenhirnstimulation im posterioren Hypothalamus zur Behandlung des chronischen Clusterkopfschmerzes. Der Schmerz. 2006 20 : 439 444.
221. Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: Long-term experience. Neurology. 2006 67 : 150 152.
222. Holland PR, Akerman S, Goadsby PJ. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci. 2006 24 : 2825 2833.
223. Rapoport AM, Bigal ME, Volcy M, Sheftell FD, Feleppa M, Tepper SJ. Naratriptan in the preventive treatment of refractory chronic migraine: A review of 27 cases. Headache. 2003 43 : 482 489.
224. Lambert GA. Looking in the wrong place? The search for an ideal migraine preventative. Drug Dev Res. 2007 68 : 376 388.
225. Swanson DR. Migraine and magnesium: Eleven neglected connections. Perspect Biol Med. 1988 31 : 526 557.
226. Goadsby PJ. Headache: Clinical and basic science advances relevant to practice. In : Flor H, Kalso E, Dostrovsky JO, eds. 11th World Congress of Pain. Sydney : International Association for the Study of Pain 2006 : 635 649.
227. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995 311 : 541 544.
228. Ferrari MD, Saxena PR. On serotonin and migraine: A clinical and pharmacological review. Cephalalgia. 1993 13 : 151 165.
229. Bocker KB, Timsit Berthier M, Schoenen J, Brunia CH. Contingent negative variation in migraine. Headache. 1990 30 : 604 609.
230. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol. 2004 61 : 1366 1368.
231. Kim JH, Suh SI, Seol HY, et al. Regional grey matter changes in patients with migraine: A voxel-based morphometry study. Cephalalgia. 2008 28 : 598 604.
232. Keller JT, Marfurt CF. Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol. 1991 309 : 515 534.
233. Lambert GA, Hoskin KL, Zagami AS. A cortical cause for migraine? Cephalalgia. 2006 26 : 1386.
234. Lambert GA, Hoskin KL, Zagami AS. Could migraine arise from the cortex? 7th IBRO World Congress of Neuroscience. Melbourne : International Brain Research Organisation 2007 : 170.
235. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994 331 : 1689 1692.
236. Sanchez del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: Spontaneous visual aura and headache. Cephalalgia. 1999 19 : 701 707.
237. Thor KB, Helke CJ. Serotonin and substance P colocalization in medullary projections to the nucleus tractus solitarius: Dual-colour immunohistochemistry combined with retrograde tracing. J Chem Neuroanat. 1989 2 : 139 148.
238. Arbab MA, Delgado T, Wiklund L, Svendgaard NA. Brain stem terminations of the trigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRP transganglionic study. J Cereb Blood Flow Metab. 1988 8 : 54 63.
239. Lang IM. Noxious stimulation of emesis. Dig Dis Sci. 1999 44 : 58S 63S.
240. Moskowitz MA. The 2006 Thomas Willis Lecture: The adventures of a translational researcher in stroke and migraine. Stroke. 2007 38 : 1645 1651.
241. Wang Y-Q, Wang J-L, Zhu C-B, Cao X-D, Wu G-C. Evidence of the synthesis of opioid receptor like 1 receptor in nociceptinergic neurons in rat brain suggests the existence of autoreceptor: A confocal double staining study. Neurosci Lett. 2000 290 : 193 196.
242. Sprouse JS, Aghajanian GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1987 1 : 3 9.
243. Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu Rev Neurosci. 2005 28 : 403 450.